Clik here to view.
HOYA Group Appoints Gerald W. Bottero Global President of PENTAX Medical
TOKYO PENTAX Medical, a division of HOYA Group, has announced the appointment of Gerald W. Bottero to the position of Global President of PENTAX Medical as of February 1st, 2016. “HOYA Group is...
View ArticleClik here to view.
ImageIQ and InvitroCue Forge Partnership to Advance Quantitative Image...
CLEVELAND & SINGAPORE ImageIQ, an innovative Imaging Software and Contract Research Organization supporting preclinical research and clinical trials, announced today an agreement with InvitroCue...
View ArticleClik here to view.
Exactech Acquires Australian Distributor
GAINESVILLE, Fla. Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today the acquisition of...
View ArticleClik here to view.
First in Asia to Develop Liver Cancer Registry Through Collaborations Among...
SINGAPORE National Cancer Centre Singapore (NCCS), Singapore Clinical Research Institute (SCRI) and IMS Health (NYSE:IMS) will collaborate to develop its first Liver Cancer or Hepatocellular...
View ArticleClik here to view.
The Institute of Cancer Research, London Sells a Portion of Its Royalty...
NEW YORK & TORONTO & TOKYO The Institute of Cancer Research, London, and DRI Capital (DRI) announced today that Drug Royalty III, a private equity fund managed by DRI, has purchased a...
View ArticleClik here to view.
Takeda Reports Results for Three Quarters (April-December) of...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Results of April to December period reaffirms full-year management guidance Underlying revenue +3.8% year-to-year (reported revenue...
View ArticleClik here to view.
武田薬品：2015年度第3四半期（4-12月期）の連結業績について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： 第3四半期（4-12月期）連結業績に照らし、年間マネジメントガイダンスを維持 売上収益の実質的な成長は、米国および新興国市場における力強い伸長により、対前年度＋3.8％（財務ベースでは対前年度＋4.0％の13,933億円）...
View ArticleClik here to view.
LCT Receives Ethics Approval for Phase IIb Parkinson’s Trial
SYDNEY & AUCKLAND, New Zealand Living Cell Technologies (ASX: LCT) (OTCQX: LVCLY) has received approval from the Northern A Health and Disability Ethics Committee for the Phase IIb clinical...
View ArticleClik here to view.
ENYO Pharma：完成总额2200万欧元的第一轮融资
法国里昂 (美国商业资讯)–日前，ENYO Pharma完成了总额2200万欧元的A轮融资。该项投资旨在帮助这家致力于开发用于治疗急慢性病毒感染药物的生物制药公司更快地开展其乙型肝炎临床项目。 这项由Sofinnova Partners携手Morningside和InnoBio完成的投资将帮助ENYO...
View ArticleClik here to view.
SCIEX and Children’s Medical Research Institute Join Forces to Advance the...
FRAMINGHAM, Mass. & SYDNEY SCIEX, a global leader in life science analytical technologies, today announced their alliance with Children’s Medical Research Institute (CMRI) to equip The...
View ArticleClik here to view.
Cytori Cell Therapy Safe and Potentially Effective in EU Phase I Erectile...
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today the publication of the results of an investigator initiated Phase I clinical trial using Cytori Cell Therapy™ for the treatment of...
View ArticleClik here to view.
Mersana Therapeutics and Takeda Expand Partnership to Advance Development of...
CAMBRIDGE, Mass. & OSAKA, Japan Mersana Therapeutics and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that they have entered a new strategic partnership granting Takeda...
View ArticleClik here to view.
ENYO Pharma announces closing of a €22 million funding round
LYON, France ENYO Pharma, a biopharmaceutical company focused on developing treatments for acute and chronic viral infections, today announced that it has secured a €22 million Series A financing...
View ArticleClik here to view.
健康产业领袖峰会激起投资热潮，中国医疗保健行业呈现两位数增长
上海 (美国商业资讯)–2015年夏季，一项活动吸引医疗保健行业的逾17万专业人士齐聚上海，打破了单日参会专业人士数量的记录。这项活动就是健康产业领袖峰会——将中国顶级医药活动结合起来的超大型贸易盛会。...
View ArticleClik here to view.
健康産業領袖峰会が2桁成長を見せる中国のヘルスケア部門に対する投資家の熱気を刺激
上海 （ビジネスワイヤ） — 2015年夏に上海で開催されたヘルスケア部門に特化したイベントに、1日に17万人以上という記録的な数の専門家が来場しました。これは、中国トップの医学・医薬品イベントを組み合わせた大規模な貿易イベントの健康産業領袖峰会（ｔHIS）です。...
View ArticleClik here to view.
NAMSA宣布剥离其无菌保障产品部门
俄亥俄州诺斯伍德 (美国商业资讯) — 世界领先的医学研究组织(MRO®) North American Science Associates, Inc. (NAMSA)今天宣布达成确定性协议，剥离其从事生物学和化学指示剂业务的无菌保障产品部门。致力于向患者、医疗照护人员和其他医疗保健提供者交付创新感染预防产品的Crosstex International, Inc....
View ArticleClik here to view.
Mersana Therapeutics與武田擴大夥伴關係，以推動 Fleximer®抗體藥物複合體和XMT-1522的開發
麻薩諸塞州劍橋和日本大阪 (美國商業資訊) — Mersana...
View ArticleClik here to view.
武田公布2015财年三个季度（4-12月）的业绩，再次确认全年的管理层指引
日本大阪 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)： 4月至12月的结果再次肯定管理层全年指引 基础营收年增长率为3.8%（报告的营收增长率为4.0%，至13,933亿日元），由美国和新兴市场的强劲业绩所主导 基础核心收益年增长率为1.5%（运营利润 -15.9%，至1,675亿日元） 基础核心EPS年增长率 为17.3%（报告的EPS增长率为43%，至145日元）...
View ArticleClik here to view.
ロンドン大学がん研究所がジョンソン・エンド・ジョンソンのザイティガの販売に伴うロイヤルティー権の一部をDri Capital Managed Fundに売却
ニューヨーク & トロント & 東京 （ビジネスワイヤ） —...
View ArticleClik here to view.
康龙化成收购Quotient Bioresearch
北京 (美国商业资讯)–康龙化成是一家全方位一体化合同研究组织(CRO)，面向药企和生物技术研发提供实验室和制造服务，该公司今天宣布收购Quotient Bioresearch (Quotient)。Quotient是一家总部位于英国的合同研究组织，拥有200多位员工，专注于整合放射化学与代谢。该专项技能的一部分来源于Quotient以往收购的GE Amersham的放射合成业务。...
View Article